Friday, July 10, 2026

pharma · Early Childhood Caries · Acute Myeloid Leukemia

University of Hong

University of Hong clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
42
Drugs
71
Patents
0
Intelligence · Clinical Programs

University of Hong projects

6 ClinicalTrials.gov programs sponsored by University of Hong.

University of Hong has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 25% AgNO3 solution followed by 5% NaF

    The University of Hong Kong

    Early Childhood Caries

    phase 3 small molecule completed

    1 trial
  2. 3-second SDF application

    The University of Hong Kong

    Early Childhood Caries

    phase 3 other completed

    1 trial
  3. Acupuncture (Procedure)

    The University of Hong Kong

    Autistic Disorder

    phase 3 other completed

    1 trial
  4. Masticatory muscle training exerciser

    The University of Hong Kong

    Mastication

    phase 3 other active

    1 trial
  5. SDF solution

    The University of Hong Kong

    Dental Caries

    phase 3 other completed

    1 trial
  6. Vortioxetine

    The University of Hong Kong

    Cannabis Use Disorder

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does University of Hong have?

6 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.